Mirum Pharmaceuticals Inc.
MIRM | NASDAQ
$92
+$0.17 (+0.19%)
At close: Sep 21, 2026, 4:00 PM ET
$92.50
+$0.50 (+0.54%)
Pre-market:
Sep 22, 2026, 9:19 AM ET
Market Data
Market Cap $5.61B
Enterprise Value $5.93B
Beta 0.49
Average Volume 885.91K
Shares Outstanding (Diluted) 63.37M
Shares Change YoY 27.44%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US6047491013
Price Performance
Price Change 1M -4.9%
Price Change 3M -17.2%
Price Change 6M 2.0%
Price Change YTD 17.8%
Price Change 1Y 24.4%
Price Change 3Y 199.5%
Price Change 5Y 397.6%
1M CAGR (ann.) -8.6%
1Y CAGR (ann.) 22.1%
5Y CAGR (ann.) 38.7%
All-Time CAGR 31.0%
Valuation
PE Ratio -6.32
Forward PE 919.57
PEG Ratio 0.00
Forward PEG 0.07
PS Ratio 9.08
Forward PS 6.90
PB Ratio -538.31
P/FCF Ratio -12.25
P/Adj. FCF Ratio -9.38
P/OCF Ratio -12.78
EV/Sales 9.60
EV/EBIT -7.39
EV/EBITDA -7.64
EV/FCF -12.95
Earnings Yield -15.8%
FCF Yield -8.2%
Adj. FCF Yield -10.7%
Financial Health
Net Debt $311.79M
Total Debt $760.54M
Cash & Short-Term Investments $438.29M
Total Assets $1.04B
Current Ratio 2.86
Quick Ratio 2.74
Debt / Equity Ratio -72.97
Debt / EBITDA -0.98
Debt / FCF -1.66
OCF / Debt -0.60
Interest Coverage -8.01
Altman Z-Score -0.32
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 81.7%
Operating Profit Margin -17.4%
EBITDA Margin -125.7%
Net Profit Margin -139.2%
FCF Margin -74.1%
Adj. FCF Margin -96.8%
SBC / Revenue 22.7%
SBC Impact (per share) -30.6%
Returns
Return on Assets -82.3%
Return on Equity -410.2%
Return on Invested Capital -13.1%
Return on Capital Employed -13.1%
Return on Tangible Assets -107.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 74.8%
Revenue CAGR 5Y 123.8%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -101.2%
EPS CAGR 5Y -45.4%
EPS CAGR 10Y N/A
FCF CAGR 3Y -126.0%
FCF CAGR 5Y -33.9%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 18
EPS Growth Next 3Y 45.1%
Revenue Growth Next 3Y 30.7%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) -$0.53
EPS Growth Est (next Q) -1151.2%
Revenue Est (next Q) $178.06M
Revenue Growth Est (next Q) 33.9%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $140.20
Price Target Upside 52.4%
Cash Flow
Operating Cash Flow $-456.03M
Free Cash Flow $-458.17M
Adj. Free Cash Flow $-598.3M
FCF Per Share -$7.23
OCF Per Share -$7.20
OCF/S Ratio -73.8%
Income Statement
Revenue $618.07M
Gross Profit $504.96M
Operating Income $-107.66M
EBITDA $-776.79M
Net Income $-860.21M
EPS (Diluted) -$14.56
Revenue / Employee $1.43M
Profit / Employee $-1.99M
Employees 433
Add to Watchlist
Select watchlists to add or remove MIRM